Cardio Diagnostics Inc.

0.45
-0.00 (-0.55%)
At close: Feb 28, 2025, 3:59 PM
0.45
-0.86%
After-hours: Feb 28, 2025, 04:18 PM EST
No 1D chart data available
Bid 0.45
Market Cap 23.67M
Revenue (ttm) 76.14K
Net Income (ttm) -17.61M
EPS (ttm) -0.3
PE Ratio (ttm) -1.51
Forward PE -2.09
Analyst Hold
Ask 0.46
Volume 1,119,303
Avg. Volume (20D) 6,364,766
Open 0.45
Previous Close 0.45
Day's Range 0.43 - 0.47
52-Week Range 0.19 - 1.82
Beta 3.55

About CDIO

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois....

Industry Biotechnology
Sector Healthcare
IPO Date Jan 14, 2022
Employees 7
Stock Exchange NASDAQ
Ticker Symbol CDIO
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for CDIO stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 340.63% from the latest price.

Buy 0.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Cardio Diagnostics Inc. is scheduled to release its earnings on Mar 31, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription